The title "Chronic exercise does not influence the effects of age and cardiovascular risk on carotid atherosclerosis" suggests an active prospective analysis. However, the data are cross-sectional.
In figures, are r values overall samples results? It should be clearly written in figures. Please insert "A" or "B" in the figure1~3.
Minor comments P2 L10, ….as well as carotid intima medial thickness, or cIMT…. is this (cIMT)? L21, 46±13 yr…. yrs P4 L25, Reference No. (6) is not healthy subjects" study. Please insert the study (6) in diabetic populations study. P7~8 P7, L21 and L42, carotid IMT is cIMT. P8, L32 and 47, carotid IMT is cIMT.
Reference Kozakova M, Palombo C, Morizzo C, Nolan JJ, Konrad T, Balkau B (2010)Effect of sedentary behaviour and vigorous physical activity on segment-specific carotid wall thickness and its progression in a healthy population. Eur Heart J 31:1511-1519.
REVIEWER
Hester den Ruijter UMC Utrecht, Utrecht, the Netherlands REVIEW RETURNED 09-Jan-2014
GENERAL COMMENTS
The paper by Parker et al. describes the cross sectional relation between exercise and vascular health indices in trained runners versus untrained spouses. The y conclude that endurance exercise training improves traditional cardiovascular risk factors, but that this more favorable cardiovascular risk is not translated to a less thick carotid intima-media thickness in runners.
The authors are congratulated with their work. This work may shed some more light on that the mechanism by which exercise may improve cardiovascular health seems independent on progression of atherosclerosis. I have the following comments; 1. Is the study powered for showing any effect of exercise on carotid atherosclerosis. Please provide a sensible power calculation. 2. I understand the choice for spouses as controls, yet they show to be very active as well, except for vigorous exercise. These controls have an almost 4h per day period of exercise. The authors may think of altering the conclusion and specifically state that the difference between runners and controls exists of ~1.5 hours of vigorous exercise. 3. It is hard to distinguish diet from exercise and the associated changes in cardiovascular risk factors. Therefore, I would suggest to show the multivariate analysis using CIMT as an outcome, and exercise, diet as variables next to the other cardiovascular risk factors. Please provide the associated multivariate beta"s of all the variables in the model. 4. Is there any information on how long these runners are doing this endurance exercise? It may be worthwhile to stratifying on this parameter. For example, if they are training for less than 6 months, it is expected that there will be no effect on IMT. 5. The authors acknowledge that probably other mechanisms may contribute to the beneficial effect of training on vascular health. To underscore this, why don"t they show C-RP levels to provide information on inflammatory status, as well as a marker on coagulation. This would certainly strengthen the manuscript. 6. Family history of CVD may be a confouder and the authors may want to re-do their analysis excluding the genetic burdened CVD subjects. Is there any difference in IMT between subjects with a family history of CVD and those without? It seems that those who feel that they have a predisposition for CVD may do more exercise. 7. I find the presentation with Framingham risk score difficult as so many individuals have a very low FRS. Also, the age of the runners would not even qualify them for scoring FRS. In this case the author may consider constructing their "own" score in which there is more variation in risk.
I wonder whether the results are presented in the best way. The fact that the study has a lot of confounding required multivariate analysis whcih has not been performed optimally
VERSION 1 -AUTHOR RESPONSE
Reviewer Name Yuko Gando 1. The prospective study with large number of subjects has already been published (Kozakova, et al. 2010 ). This study suggested that the 3-year IMT progression was reduced in subjects with some bouts of vigorous-intensity activity. The authors should quote this reference and discuss about the difference in outcome. Thank you. We have included this in the discussion and speculate that possible differences could be do to age in the study population (as authors of the Kozkova study noted, the population was relatively young and the longitudinal followup only 3 years).
2. The title "Chronic exercise does not influence the effects of age and cardiovascular risk on carotid atherosclerosis" suggests an active prospective analysis. However, the data are cross-sectional. We have provided the reviewer with the following language from the original protocol: All sample size calculations were made with PSPower 3.0.4. The primary outcome of interest in the current study is carotid atherosclerosis (estimated by cIMT) between runners and non-running controls. A recent study by Gando et al. 2011 found a significant difference in cIMT between fit and unfit older subjects (0.69±0.01 vs. 0.74±0.01 mm, respectively). We are planning a study of a continuous response variable from independent control and experimental subjects with 1 control(s) per experimental subject. Gando et al. found that the response within each subject group was normally distributed with standard deviation 0.01. If the true difference in the experimental and control means is 0.05, we would need to study 2 experimental subjects and 2 control subjects to be able to reject the null hypothesis that the population means of the experimental and control groups are equal with probability (power) 0.8. The Type I error probability associated with this test of this null hypothesis is 0.05. Given the potential influence of environmental factors, diet and other lifestyle factors on the outcome, we expect that the true population difference could be dramatically lower. Using the minimum detectable difference of approximately 0.01 mm (or 20% of the group mean difference observed by Gando et al.), we would need 17 subjects/group to reject the null hypothesis. Consequently, we plan to overpower our sample with 50/group in order to investigate as covariates and factors other potential predictors (Framingham risk score, gender, age, training status) in order to inform future investigations and explore alternative interpretations to the data. 2. I understand the choice for spouses as controls, yet they show to be very active as well, except for vigorous exercise. These controls have an almost 4h per day period of exercise. The authors may think of altering the conclusion and specifically state that the difference between runners and controls exists of ~1.5 hours of vigorous exercise. Please note that controls did not engage in regular, sweat-provoking exercise 2 or more times/week and thus were not vigorous exercisers. In addition, we have identified this as a limitation in the following manner: Our control subjects were also not entirely sedentary. Controls performed less vigorous exercise, but they did perform similar amounts of moderate exercise as the runners. This design may enhance the validity of our study, however, because it might better isolate the influence of habitual, high-intensity exercise training on cardiovascular risk and carotid atherosclerosis. Therefore we respectfully state that our conclusions are based on the observed training differences between the subjects and their control spouses. 3. It is hard to distinguish diet from exercise and the associated changes in cardiovascular risk factors. Therefore, I would suggest to show the multivariate analysis using CIMT as an outcome, and exercise, diet as variables next to the other cardiovascular risk factors. Please provide the associated multivariate beta"s of all the variables in the model. We chose not to express data in this manner because when we ran multiple linear regression analyses of all cardiovascular risk factors and diet/exercise vs left or right cIMT, only age was a significant predictor in the model. Taking age out of the model yielded only Framingham risk score as a significant predictor in the model. Therefore, adding additional multiple regression analyses into the paper did not provide substantial information since the univariate analyses of age and Framingham risk were the only significant predictors in the multivariate model. We have added this into the statistical analyses section of the manuscript for clarification. 4. Is there any information on how long these runners are doing this endurance exercise? It may be worthwhile to stratifying on this parameter. For example, if they are training for less than 6 months, it is expected that there will be no effect on IMT.
As noted in Table 1 , there was a broad range of running experience (average years spent training at current marathon mileage was 12 ± 10 years). It is difficult to explore the relationship between years spent running and cIMT because in the sample years spent running was strongly correlated to age, as would be expected (Pearson Correlation = 0.36 and p < 0.01). However, to address the reviewer"s question we ran partial correlation analyses controlling for years run to see if the relationship between cIMT and age or Framingham risk was altered within the running group. When we controlled for years run in this manner, there were still significant relationships between left and right cIMT, age and Framingham risk (all p < 0.01). Therefore we do not believe that years run modifies the relationship between exercise, age, cardiovascular risk and cIMT and we have included a sentence to this effect in the results. 5. The authors acknowledge that probably other mechanisms may contribute to the beneficial effect of training on vascular health. To underscore this, why don"t they show C-RP levels to provide information on inflammatory status, as well as a marker on coagulation. This would certainly strengthen the manuscript. Please note that Table 1 includes hsCRP levels (which were higher in runners than in controls). We do not have any coagulatory markers as this would have required specialized blood collection planned prior to the study and we did not have the funds to conduct such an analysis. 6. Family history of CVD may be a confouder and the authors may want to re-do their analysis excluding the genetic burdened CVD subjects. Is there any difference in IMT between subjects with a family history of CVD and those without? It seems that those who feel that they have a predisposition for CVD may do more exercise. We thank the author for this suggestion. When we excluded individuals with a family history of CVD from the analysis there was no difference in results. For example, cIMT was not different between runners and controls (p = 0.14 and 0.67 or left and right cIMT, respectively). Therefore excluding the genetically burdened CVD subjects did not influence our interpretations our conclusions. 7. I find the presentation with Framingham risk score difficult as so many individuals have a very low FRS. Also, the age of the runners would not even qualify them for scoring FRS. In this case the author may consider constructing their "own" score in which there is more variation in risk. We thank the reviewer for this suggestion but have respectfully chosen not to do this because we believe that clinicians will find more value in a traditionally utilized and accepted clinical scoring methodology such as Framingham.
VERSION 2 -REVIEW REVIEWER
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GENERAL COMMENTS
If the statistical reviewer agrees that the data are analysed most appropriately, I would agree to publication
